Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹372.6Prev. Close
₹368.95Turnover(Lac.)
₹503.67Day's High
₹377.95Day's Low
₹370.0552 Week's High
₹425.1552 Week's Low
₹273.8Book Value
₹51.91Face Value
₹2Mkt Cap (₹ Cr.)
4,196.2P/E
34.07EPS
11.02Divi. Yield
1.3611 May 2024
12:00 AM
Dividend
Dividend Amount: 4
Record Date: 18 May, 2024
6 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
8 Jul 2023
12:00 AM
AGM
Announcement Date: 08 Jul, 2023
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 22.37 | 22.37 | 22.36 | 22.35 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 558.11 | 502.97 | 457.99 | 413.1 |
Net Worth | 580.48 | 525.34 | 480.35 | 435.45 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 272.79 | 283.47 | 247.35 | |
yoy growth (%) | -3.76 | 14.6 | ||
Raw materials | -99.2 | -96.3 | -88.75 | |
As % of sales | 36.36 | 33.97 | 35.88 | |
Employee costs | -39.31 | -34.23 | -32.6 | -32.48 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 72.07 | 98.42 | 75.85 | |
Depreciation | -9.56 | -9 | -8.81 | -7.81 |
Tax paid | -17.56 | -27.41 | -17.89 | |
Working capital | 37.12 | -10.33 | 26.58 | -6.36 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -3.76 | 14.6 | ||
Op profit growth | -27.86 | 31.19 | ||
EBIT growth | -26.75 | 28.03 | ||
Net profit growth | -23.23 | 22.52 | 61.47 | 3.81 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 623.87 | 540.64 | 529.38 | 501.84 | 443.99 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 623.87 | 540.64 | 529.38 | 501.84 | 443.99 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 36.66 | 25.46 | 6.42 | 8.85 | 5.64 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,527.65 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,585.45 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,486.95 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,106.3 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,438.35 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time director
MUKUND MADHUSUDAN KABRA
Independent Director
KEDAR JAGDISH DESAI
Chairman (Non-Executive)
VASANT RATHI
Independent Director
Pramod Kasat
Company Sec. & Compli. Officer
Sanjay Basantani
Independent Director
Rajesh Kumar Sharma
Non-Exec & Non-Independent Dir
Rasika Rathi
Independent Director
Vindokumar Hiralal Jajoo
Non-Exec & Non-Independent Dir
Sunny Sharma
Independent Director
Rajshree Patel
Independent Director
NITIN JAGANNATH DESHMUKH
Independent Director
Vandana Tilak.
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Advanced Enzyme Technologies Ltd
Summary
Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that has transformed business globally in the manufacturing of enzymes by improving the fundamentals based on research and technology. The Company is engaged in the research and development, manufacturing and marketing of over 400 proprietary products developed from over 68 indigenous enzymes and probiotics. It has manufacturing facilities and research & development centers across India, Germany and the US. Advanced Enzyme Technologies Limited (AETL) was incorporated, as a Private Limited Company on March 15, 1989 under the provisions of the Companies Act, 1956 as Advanced Biochemicals Private Limited in Maharashtra. Pursuant to a Special Resolution passed by the Shareholders of the Company at the Extra-Ordinary General Meeting held on April 21, 1992, the Company was converted into a Public Limited Company and consequently, name of the Company got changed to Advanced Biochemicals Limited. A fresh Certificate of Incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra on May 28, 1992. Pursuant to a Special Resolution passed by the Shareholders of the Company at the Extra-Ordinary General Meeting held on August 8, 2005, name of the Company was further changed from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. A fresh Certificate of Incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra, Mumbai on August 19,
Read More
What is the Advanced Enzyme Technologies Ltd share price today?
The Advanced Enzyme Technologies Ltd shares price on nse is Rs.₹375.25 today.
What is the Market Cap of Advanced Enzyme Technologies Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Advanced Enzyme Technologies Ltd is ₹4196.20 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Advanced Enzyme Technologies Ltd?
The PE and PB ratios of Advanced Enzyme Technologies Ltd is 34.07 and 7.23 as of 03 Jul ‘24
What is the 52 Week High and Low of Advanced Enzyme Technologies Ltd?
The 52-week high/low is the highest and lowest price at which a Advanced Enzyme Technologies Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Advanced Enzyme Technologies Ltd is ₹273.8 and ₹425.15 as of 03 Jul ‘24
What is the CAGR of Advanced Enzyme Technologies Ltd?
Advanced Enzyme Technologies Ltd's CAGR for 5 Years at 16.31%, 3 Years at -3.27%, 1 Year at 30.51%, 6 Month at -1.53%, 3 Month at 1.12% and 1 Month at 2.47%.
What is the shareholding pattern of Advanced Enzyme Technologies Ltd?
The shareholding pattern of Advanced Enzyme Technologies Ltd is as follows:
Promoters - 43.49 %
Institutions - 30.57 %
Public - 25.94 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
